Medical Oncologist, Dermatologist and Director of the Center for Merkel Cell Carcinoma at the Mass General Cancer Center
Joined December 2019
- Tweets385
- Following487
- Followers488
- Likes749
David M. Miller MD, PhD, FAAD retweeted
There’s still time! Don’t miss the latest CME activity on the role of immunotherapy in nonmelanoma skin cancer. #MedEd #CME #MedTwitter #Skin #DermTwitter
ow.ly/TCtM50OYxwz
Looking forward to another great discussion with my good friend Vishal Patel!
Explore Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer with leading experts Dr. Miller @TheMillerLab and Dr.Patel!
Register now for Monday, June 26th at 7:00 PM ET: medlearninggroup.com/cme-pro…
#Virtual #CME #Immunotherapy #MedTwitter #MedLearningGroup
ALT Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer
David M. Miller MD, PhD, FAAD retweeted
Explore Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer with leading experts Dr. Miller @TheMillerLab and Dr.Patel!
Register now for Monday, June 26th at 7:00 PM ET: medlearninggroup.com/cme-pro…
#Virtual #CME #Immunotherapy #MedTwitter #MedLearningGroup
ALT Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer
David M. Miller MD, PhD, FAAD retweeted
Thx to Laura Ferris, Nikhi Khushalani, Kevin Emerick, Sonia Cohen, Sameer Gupta, Ryan Sullivan, @bosques12, @EmilyKimMed, @BhatiaS_MD, @MunTheLoon & @TheMillerLab for another great Journal Club discussion of the @USPSTF recs re: skin cancer screening
jamanetwork.com/journals/jam…
Thanks Sridhar, can’t wait to see your customizations.
Great session today at @r_medicine, enjoyed being introduced to the StoryboardR package from @TheMillerLab @MGHMedicine, excited to try the package and for the potential future adaptations #RMed2023 #rstats
Really enjoyed learning from Drs. Vishal Patel and Axel Haushild. Thanks RMEI for putting together this great program.
Last Chance! Join us for a no-fee CME activity to gain valuable insights on #immunotherapy in #NMSC. #MedEd #CME #MedTwitter #DermTwitter #OncTwitter
rmei.com/ce_activity/seeing-…
David M. Miller MD, PhD, FAAD retweeted
I'm excited to live stream #rstats #shiny app dev for @r_medicine 2023! We'll explore a licorice study with:
🦏 {rhino} @appsilon
🔍 Summary tables {Tplyr} @AtorusR & {reactable}
⭐️ Dashboard UI from {bslib} @cpsievert
📆 June 8 (1 PM EDT/7 PM CEST)
📡 twitch.tv/rpodcast
David M. Miller MD, PhD, FAAD retweeted
David Miller & Sophia Shalhout with @MGHMedicine & @MassEyeAndEar, will be giving a session presentation on “StoryboardR: An R package and Shiny application designed to visualize real-world data from clinical patient registries” at #RMed2023. #Rstats ➡️ events.linuxfoundation.org/r…
ALT Below the R/Med logo there is text "StoryboardR" and "David Michael Miller, Oncologist at Massachusetts General Hospital" and ""Sophia Z. Shalhout Principal Investigator, Mass Eye and Ear/Harvard Medical School"
David M. Miller MD, PhD, FAAD retweeted
🎉 The excitement is building as we count down for our Complimentary Virtual CME/CNE Program on NMSC!
Join Dr. Miller @TheMillerLab and Dr. Patel TONIGHT at 7:30 PM EST!
Register Now: ow.ly/HZUo50OBUVO
#oncology #MedTwitter #VirtualEvent #CME #CNE #MedLearningGroup
ALT The Emerging Standard of Care: Immunotherapy in Non-Melanoma Skin Cancer
Important work Glenn, kudos.
A head and neck oncologist crashing the melanoma/skin cancer party. 🤪👍🏼Durable responses and NO kidney rejection for mTOR/pred+Cemiplimab in KTRs with metastatic CSCC — 👀😱@evanlipson @DanaFarberNews @DanaFarber @ASCO #ASCO2023
Excited for the upcoming #RMed2023. Always one of my favorite events of the year. Looking forward to presenting StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries with @SophiaShalhout.
#Rstats @r_medicine
Looking forward to hearing from our esteemed panelists @KYTsaiLab and Dr. Michael Migden along with co-chair Dr. Michael K Wong in our upcoming @MedscapeLIVE event:
na.eventscloud.com/website/5…
It should make for a great discussion.
David M. Miller MD, PhD, FAAD retweeted
Experience our Complimentary Live Virtual CME/CNE Program featuring NMSC on Monday, 6/5, at 7:30 PM ET with Dr. Miller @TheMillerLab and Dr. Patel!
Register now: medlearninggroup.com/cme-pro…
#Immunotherapy #MedicalEducation #VirtualEvent #CME #CNE #MedLearningGroup
ALT The Emerging Standard of Care: Immunotherapy in Non-Melanoma Skin Cancer
David M. Miller MD, PhD, FAAD retweeted
Explore the latest melanoma therapies and the significant role of anti-LAG3 antibodies with Dr. Miller @TheMillerLab!
Learn more about this activity: ow.ly/13yc50Nu3fm
#SkinCancerAwareness #Melanoma #immunotherapy #CME #medicaleducation #medlearninggroup
ALT The ACTIVATE Initiative Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role
David M. Miller MD, PhD, FAAD retweeted
Does immune checkpoint inhibitor therapy increase the risk of cardiovascular events? Check out this "Perspectives On The Science" article in #JoCO (@CutaneousOnc ) from #SoCO members @TheMillerLab, @SophiaShalhout et al.
doi.org/10.59449/joco.…
#Cancer
David M. Miller MD, PhD, FAAD retweeted
Is there a connection between immunotherapy and cardiovascular events such as MI and stroke? Check out the latest Perspectives on the Science piece in #JoCO by @TheMillerLab, @sophiashalhout, et al.
doi.org/10.59449/joco.2023.0…
#Cancer #Immunotherapy
David M. Miller MD, PhD, FAAD retweeted
Fri June 9 keynote at R/Med 2023 from Jeff Leek of Fred Hutch Cancer Center, at 11 AM ET for the west coast. Jeff will start with Building the Fred Hutch DS Lab, w/a side quest on Non-profit DS training to solve the problems of economic opportunity deserts & diversity in DS
David M. Miller MD, PhD, FAAD retweeted
Shedding new light on the dark side of cancer immunotherapy - mechanisms of IRAEs. Just out in @ScienceTM, grateful for support from @UCLAHealth and @AmThyroidAssn and my collaborators @DoctorAngell @MaureenSuLab wix.to/yPSqMbG